DCF — EVERGREEN HEALTH MONROE
Enterprise Value: $-77.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-77.0M
Enterprise Value
$-24.4M
PV of Cash Flows
$-52.6M
PV of Terminal Value
$-84.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $48.4M | $-4.8M | -10.0% | $-6.8M | $-6.2M |
| Year 2 | $49.8M | $-4.4M | -9.0% | $-6.5M | $-5.4M |
| Year 3 | $51.3M | $-4.1M | -8.0% | $-6.2M | $-4.7M |
| Year 4 | $52.8M | $-3.9M | -7.0% | $-6.1M | $-4.2M |
| Year 5 | $54.4M | $-3.9M | -7.0% | $-6.2M | $-3.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-77.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$46.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.10406745258072524
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5